Prostate cancer-specific mortality after radical prostatectomy or external beam radiation therapy in men with 1 or more high-risk factors (Q80388277)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17530618%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

title

Prostate cancer-specific mortality after radical prostatectomy or external beam radiation therapy in men with 1 or more high-risk factors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17530618%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

1

Anthony V D'Amico

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17530618%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

Ming-Hui Chen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17530618%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

William J Catalona

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17530618%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Leon Sun

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17530618%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Kimberly A Roehl

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17530618%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Judd W Moul

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17530618%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

publication date

1 July 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17530618%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17530618%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

110

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17530618%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17530618%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

56-61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17530618%20AND%20SRC:MED&resulttype=core&format=json

Changing nature of high risk patients undergoing radical prostatectomy

31 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22737

7 January 2021

Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22737

7 January 2021

Cancer-specific mortality after radiation therapy with short-course hormonal therapy or radical prostatectomy in men with localized, intermediate-risk to high-risk prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22737

7 January 2021

Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22737

7 January 2021

Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22737

7 January 2021

Six-month androgen suppression plus radiation therapy compared with radiation therapy alone for men with prostate cancer and a rapidly increasing pretreatment prostate-specific antigen level

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22737

7 January 2021

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22737

7 January 2021

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22737

7 January 2021

Hydrocortisone with or without mitoxantrone in men with hormone-refractory prostate cancer: results of the cancer and leukemia group B 9182 study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22737

7 January 2021

Pretreatment PSA velocity and risk of death from prostate cancer following external beam radiation therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22737

7 January 2021

The interpretation of serum prostate specific antigen in men receiving 5alpha-reductase inhibitors: a review and clinical recommendations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22737

7 January 2021

Identifiers

DOI

10.1002/CNCR.22737

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17530618%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference